Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Barbieri

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 5, 2012
Interleukin-1β causes anxiety by interacting with the endocannabinoid systemSilvia Rossi, Lucia Sacchetti, Francesco Napolitano, et al.
Biologics : Targets & Therapy|February 28, 2020
Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre StudyMarco A Cimmino, Massimiliano Parodi, Francesca Barbieri, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 30, 2026
Synthesis and Biological Evaluation of Novel Carbazole Derivatives as Broad-Spectrum Antibacterial Agents to Fight Antimicrobial Resistance (AMR)Maria Grazia Martina, Francesca Barbieri, Sacha Michèle Idriss Cancade, et al.
Neuromolecular Medicine|March 28, 2014
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosisFrancesco Mori, Carolina G Nicoletti, Silvia Rossi, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Blood Transfusion = Trasfusione Del Sangue|December 8, 2023
Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in ItalyEpifania R Testa, Margherita Robazza, Francesca Barbieri, et al.
Clinical Science (London, England : 1979)|February 21, 2015
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosisGabriella Ruocco, Silvia Rossi, Caterina Motta, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosisFrancesco Mori, Silvia Rossi, Sonia Piccinin, et al.
European Journal of Medicinal Chemistry|September 10, 2025
Developing Type II F508del-CFTR correctors with a protective effect against respiratory virusesFrancesca Barbieri, Maria Grazia Martina, Emanuela Pesce, et al.
Plos One|July 11, 2013
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosisSilvia Rossi, Valeria Studer, Alessandro Moscatelli, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 5, 2012
Interleukin-1β causes anxiety by interacting with the endocannabinoid systemSilvia Rossi, Lucia Sacchetti, Francesco Napolitano, et al.
Biologics : Targets & Therapy|February 28, 2020
Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre StudyMarco A Cimmino, Massimiliano Parodi, Francesca Barbieri, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 30, 2026
Synthesis and Biological Evaluation of Novel Carbazole Derivatives as Broad-Spectrum Antibacterial Agents to Fight Antimicrobial Resistance (AMR)Maria Grazia Martina, Francesca Barbieri, Sacha Michèle Idriss Cancade, et al.
Neuromolecular Medicine|March 28, 2014
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosisFrancesco Mori, Carolina G Nicoletti, Silvia Rossi, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Blood Transfusion = Trasfusione Del Sangue|December 8, 2023
Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in ItalyEpifania R Testa, Margherita Robazza, Francesca Barbieri, et al.
Clinical Science (London, England : 1979)|February 21, 2015
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosisGabriella Ruocco, Silvia Rossi, Caterina Motta, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosisFrancesco Mori, Silvia Rossi, Sonia Piccinin, et al.
European Journal of Medicinal Chemistry|September 10, 2025
Developing Type II F508del-CFTR correctors with a protective effect against respiratory virusesFrancesca Barbieri, Maria Grazia Martina, Emanuela Pesce, et al.
Plos One|July 11, 2013
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosisSilvia Rossi, Valeria Studer, Alessandro Moscatelli, et al.
Pageof 6